Poland· PL-100119519
BCG - medac
A bcg-impfstoff product containing bcg ad immunocurationem, registered in Poland by medac Gesellschaft fuer klinische Spezialpraeparate mbH. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Bcg-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC L03AX03 (bcg-impfstoff), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Bcg-impfstoff · ATC L03AX03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- BCG ad immunocurationem
- Manufacturer
- medac Gesellschaft fuer klinische Spezialpraeparate mbH
- Country
- Poland (PL)
- ATC code
- L03AX03
- ATC class
- BCG-Impfstoff
- Defined daily dose
- 0.033 Darreichungsform, intravesikal
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991021818
- gtin04037353332225
- gtin05909991021825
- gtin05909991021832
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L03AX03
Bcg-impfstoff, as other registers publish it.
- DenmarkBCG "medac"Medac, Gesellschaft für klinische Spezialpräparate mbH
- SwitzerlandBCG Apogepha 100 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen AnwendungRegulix GmbH
- SwitzerlandBCG Apogepha 50 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen AnwendungRegulix GmbH
- DenmarkBCG medac2care4 ApS
- CzechiaBCG MEDACMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- CzechiaBCG MEDACMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- CzechiaBCG MEDACMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- CzechiaBCG MEDACMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5b860258-f1cb-401c-b539-0784894c0f12 GET /v1/drugs/5b860258-f1cb-401c-b539-0784894c0f12?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania zawiesiny do pęcherza moczowego",
"source": "urpl",
"strength": "min. 2x10^8 max. 3x10^9/50 ml",
"packaging": "05909991021818 ¦ Rpz ¦ 22268\n1 fiol. proszku ¦ 1 system 50 ml rozp. do rekonstytucji i podawania\n¦ UR/Z/4c/063/23 - 04037353332225 ¦ UR/Z/4c/163/23 - 04037353332225\n05909991021825 ¦ Rpz ¦ 22269\n3 fiol. proszku ¦ 3 systemy 50 ml rozp. do rekonstytucji i podawania\n05909991021832 ¦ Rpz ¦ 22270\n5 fiol. proszku ¦ 5 systemów 50 ml rozp. do rekonstytucji i podawania",
"substance": "żywe cząstki BCG, szcep RIVM wytworzony ze szczepu 1173-P2 min. 2x10^8 max. 3x10^9",
"common_name": "BCG ad immunocurationem",
"pl_product_id": "100119519",
"pozwolenie_nr": "10218",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about bcg-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.